A question for those who understand the procedural end of things vis a vis the regulating bodies....

Let's say everything goes well with BETonMACE....theres a thumbs up on Futility and then the trial reaches its conclusion and basically proves what the company was hoping to prove RRR of MACE is 40, 50, 80%...whatever....whooop dee doo, we all party.

But what about the patients?  Say there's a guy in his 60s or 70s who was part of the dosed group....if I understand things correctly patients don't know if they're in the dosed group or the placebo group.  But let's give someone a name...Joe Patient, JP for short.  

JP doesn't know if he's been taking sugar pills or Apabetalone....okay.  But I would have to assume, he'd be told how his LDL and HDL are doing.....and if JP knows that he's in better health, bad cholesterol down and good cholesterol up....and he had a stroke 3 months before starting the trial, but now he's feeling much better and everything is checking out health wise.

Question....Does he have to wait if he wants to keep taking the drug?